Table 1 Serological findings and general clinical and demographic data according to study year: seropositive = >10 IU/mL; low titer = 10–15 IU/mL; GA – gestational age in weeks; age sampling – mean age of sampling in days; BP % – percentage of subjects havinh received blood/blood products; maternal age – mean age of mothers; SD standard deviation, CI confidence interval
From: Rubella immune status of neonates – a window towards seroprevalence among childbearing women
Total | 2010 | 2011 | p | |
|---|---|---|---|---|
Serological findings | ||||
Seropositive (%) | 540/599 (90.2 %) | 380/406 (93.6 %) | 160/193 (82.9 %) | <0.0001 |
Mean IgG titer (SD) | 71 IU/mL (62) | 79 IU/mL (62) | 46 IU/mL (57) | <0.0001 |
% low titer IgG (95 % CI) | 5 (3.5–7) | 4.9 (3.2–7.5) | 5.2 (2.8–9.2) | -- a |
Clinical and demographic data | ||||
Male No (%) | 311 (51.4 %) | 201 (49.6 %) | 104 (53.6 %) | -- |
Female No (%) | 294 (48.6 %) | 204 (50.4 %) | 90 (46.4 %) | -- |
GA (SD) | 32.7 (3.8) | 32.5 (3.9) | 32.9 (3.5) | -- |
Mean age of neonates (SD) | 18.6 (22.1) | 20.1 (24.3) | 16.9 (19.2) | -- |
BP % (95%CI) | 34.7 (31.0–38.6) | 35.1 (30.6–39.8) | 32.6 (26.4–39.5) | -- |
Maternal age in years (range) | 30.2 (15–48) | 30.1 (16–48) | 30.3 (15–45) | -- |